Arthritis Res Ther. 2009;11(5):128. Epub 2009 Oct 6.

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.

Abstract

The efficacy of B-cell depletion therapy in rheumatoid arthritis (RA) has led to a renewed interest in B cells and their products and the role they play in the pathogenesis of the disease. Agents blocking tumour necrosis factor (TNF) are also very effective in the treatment of RA. It has long been known that the use of anti-TNF therapy can be associated with development of anti-nuclear and anti-double-stranded DNA antibodies and, more rarely, a lupus-like syndrome. Recently, studies have been published investigating further possible effects of anti-TNF agents on B cells and whether these could contribute to their effectiveness in RA.

Comment on

Arthritis Res Ther. 2009;11(3):R84.

PMID:: 19818166; [PubMed - indexed for MEDLINE]
PMCID: PMC2787257

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. [Arthritis Rheum. 2007]
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Arthritis Rheum. 2007 May; 56(5):1417-23.
Review Immunological therapies for rheumatoid arthritis. [Br Med Bull. 2005]
Review Immunological therapies for rheumatoid arthritis.
Edwards CJ. Br Med Bull. 2005; 73-74:71-82. Epub 2005 Sep 20.
Review B cell therapies for rheumatoid arthritis: beyond B cell depletion. [Rheum Dis Clin North Am. 2010]
Review B cell therapies for rheumatoid arthritis: beyond B cell depletion.
Calero I, Nieto JA, Sanz I. Rheum Dis Clin North Am. 2010 May; 36(2):325-43.
Review [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis]. [Rev Med Interne. 2000]
Review [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
Mugnier B, Bouvenot G. Rev Med Interne. 2000 Oct; 21(10):854-62.
No B cells--no active RA? Advances in B cell depletion in RA--repeated therapy under conditions of clinical practice. [Rheumatology (Oxford). 2007]
No B cells--no active RA? Advances in B cell depletion in RA--repeated therapy under conditions of clinical practice.
Dörner T, Burmester GR. Rheumatology (Oxford). 2007 Apr; 46(4):563-4. Epub 2007 Mar 3.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
Arthritis Res Ther. 2009 ;11(5):128. Epub 2009 Oct 6 .

PubMed
Can sustained arousal explain the Chronic Fatigue Syndrome?
Can sustained arousal explain the Chronic Fatigue Syndrome?
Behav Brain Funct. 2009 Feb 23 ;5:10.

PubMed
Simulation of propofol anaesthesia for intracranial decompression using brain hy...
Simulation of propofol anaesthesia for intracranial decompression using brain hypothermia treatment.
Theor Biol Med Model. 2007 Nov 29 ;4:46.

PubMed
Reaching in reality and virtual reality: a comparison of movement kinematics in ...
Reaching in reality and virtual reality: a comparison of movement kinematics in healthy subjects and in adults with hemiparesis.
J Neuroeng Rehabil. 2004 Dec 14;1(1):11.

PubMed
Influenza virus antigenic variation, host antibody production and new approach t...
Influenza virus antigenic variation, host antibody production and new approach to control epidemics.
Virol J. 2009 Mar 13 ;6:30.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: